Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEE
1751
DELISTED
Sealed Air
SEE
| $20.7M | 0.01% |
+358,070
| New | +$22.6M |
|
1752
CALL
ARK Genomic Revolution ETF
ARKG
$1.74B
| $20.6M | 0.01% |
655,000
-20,300
| -3% | -$710K |
|
1753
Gray Television
GTN
$538M
| $20.5M | 0.01% |
1,216,596
+449,329
| +59% | +$8.73M |
|
|
GTM
1754
PUT
ZoomInfo Technologies
GTM
$1.18B
| $20.5M | 0.01% |
617,500
+347,700
| +129% | +$15.3M |
|
1755
RLI Corp
RLI
$5.85B
| $20.5M | 0.01% |
352,092
+6,392
| +2% | +$366K |
|
1756
CALL
ProShares UltraPro S&P 500
UPRO
$5.82B
| $20.5M | 0.01% |
588,600
+262,100
| +80% | +$12.2M |
|
1757
CNX Resources
CNX
$5.28B
| $20.5M | 0.01% |
1,244,850
+1,222,115
| +5,375% | +$25M |
|
1758
Vanguard International Dividend Appreciation ETF
VIGI
$9.29B
| $20.5M | 0.01% |
298,200
+74,777
| +33% | +$5.48M |
|
|
CNR
1759
Core Natural Resources Inc
CNR
$4.76B
| $20.4M | 0.01% |
414,149
+337,683
| +442% | +$16.4M |
|
|
SJIV
1760
DELISTED
South Jersey Industries, Inc. Corporate Units
SJIV
| $20.4M | 0.01% |
300,592
-1
| -0% | -$69 |
|
1761
CALL
Canadian Natural Resources
CNQ
$98.9B
| $20.4M | 0.01% |
775,960
+63,302
| +9% | +$1.92M |
|
1762
PUT
Direxion Daily Small Cap Bear 3x ETF
TZA
$196M
| $20.4M | 0.01% |
43,716
+31,846
| +268% | +$12.8M |
|
1763
Intellia Therapeutics
NTLA
$1.67B
| $20.4M | 0.01% |
393,938
-92,495
| -19% | -$4.7M |
|
1764
PUT
IQVIA
IQV
$39B
| $20.4M | 0.01% |
93,900
+34,100
| +57% | +$7.41M |
|
|
1765
CALL
ResMed
RMD
$32.6B
| $20.3M | 0.01% |
97,000
-26,100
| -21% | -$5.56M |
|
1766
Insperity
NSP
$1.99B
| $20.3M | 0.01% |
203,404
+89,269
| +78% | +$8.84M |
|
1767
LendingTree
TREE
$458M
| $20.3M | 0.01% |
462,917
+133,047
| +40% | +$9.86M |
|
|
RXRA
1768
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
| $20.3M | 0.01% |
2,071,530
+70,077
| +4% | +$686K |
|
1769
Principal Financial Group
PFG
$24.4B
| $20.3M | 0.01% |
303,429
+241,976
| +394% | +$17M |
|
|
NVO
1770
PUT
Novo Nordisk
NVO
$201B
| $20.2M | 0.01% |
363,200
+16,200
| +5% | +$899K |
|
1771
Eagle Materials
EXP
$6.4B
| $20.2M | 0.01% |
183,884
+110,656
| +151% | +$13.6M |
|
1772
Edgewise Therapeutics
EWTX
$4.8B
| $20.2M | 0.01% |
2,538,018
-101,782
| -4% | -$769K |
|
1773
Trade Desk
TTD
$6.64B
| $20.2M | 0.01% |
481,896
+20,657
| +4% | +$1.13M |
|
1774
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $20.2M | 0.01% |
395,255
+386,774
| +4,560% | +$20.2M |
|
|
NSTB
1775
DELISTED
Northern Star Investment Corp. II
NSTB
| $20.1M | 0.01% |
2,047,900
-1,129,253
| -36% | -$11.1M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.